<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this article was to review the literature on synchronous <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> (PC) from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Synchronous PC of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> origin is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disease</z:e> with an incidence ranging from 4 to 7% of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and is exclusively peritoneal in half of cases </plain></SENT>
<SENT sid="2" pm="."><plain>Synchronous PC is more frequently associated with <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> that are at an advanced stage </plain></SENT>
<SENT sid="3" pm="."><plain>After macroscopically complete resection (R0/R1) of synchronous PC, without associated intraperitoneal chemotherapy, the 5-year survival rates range from 24 to 36% </plain></SENT>
<SENT sid="4" pm="."><plain>Complete cytoreductive surgery plus intraperitoneal chemotherapy at the time of diagnosis is probably the best therapeutic option </plain></SENT>
<SENT sid="5" pm="."><plain>If no intraperitoneal treatment can be given, no resection should be performed and an accurate description should be made </plain></SENT>
<SENT sid="6" pm="."><plain>If a limited synchronous PC has been resected with the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> without intraperitoneal treatment, the authors recommend a systematic second-look surgery in an experienced center </plain></SENT>
</text></document>